InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2024-08-05 00:00:00 ET · period of report 2024-08-01 · accession 0001628280-24-034809 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-08-05 2024-08-02 TDOC Waters Michael Willem COO S - Sale+OE $8.14 -6,053 74.2K -8% -$49.3K
D 2024-08-05 2024-08-01 TDOC Waters Michael Willem COO M - OptEx — +11.3K 80.3K +16% —
D 2024-08-05 2024-08-01 TDOC Waters Michael Willem COO M - OptEx $0.00 -11.3K 45.3K -20% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-08-02 S D 6,053 $8.14 74,214 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
2 Common Common Stock 2024-08-01 M A 11,319 — 80,267 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
3 Derivative Restricted Stock Units 2024-08-01 M D 11,319 $0.00 45,280 D — · — to — 11,319 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.